Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Plaque Psoriasis”

267 trials

Showing 20 of 267 results

Post-approval studies (Phase 4)Study completedNCT03506477
What this trial is testing

Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color

Who this might be right for
Plaque PsoriasisPsoriasis
Icahn School of Medicine at Mount Sinai 25
Large-scale testing (Phase 3)Study completedNCT02581345
What this trial is testing

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPsoriasis
Momenta Pharmaceuticals, Inc. 572
Large-scale testing (Phase 3)Study completedNCT04211363
What this trial is testing

Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Arcutis Biotherapeutics, Inc. 439
Testing effectiveness (Phase 2)Study completedNCT03230292
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 43
Large-scale testing (Phase 3)Study completedNCT00258713
What this trial is testing

A 36-Week Extension to Protocol ISA04-03

Who this might be right for
Psoriasis
Aurinia Pharmaceuticals Inc. 309
Large-scale testing (Phase 3)Study completedNCT00235820
What this trial is testing

Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 271
Post-approval studies (Phase 4)UnknownNCT05555797
What this trial is testing

Excimer Laser With Topical Agents in Psoriasis Vulgaris

Who this might be right for
Psoriasis
Assiut University 30
Testing effectiveness (Phase 2)Study completedNCT02223039
What this trial is testing

Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbGenomics B.V Taiwan Branch 50
Not applicableStudy completedNCT00098189
What this trial is testing

Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Novartis
Testing effectiveness (Phase 2)Study completedNCT00678210
What this trial is testing

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 197
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Testing effectiveness (Phase 2)Study completedNCT01537432
What this trial is testing

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Who this might be right for
Psoriasis, Plaque-type Psoriasis
Novartis Pharmaceuticals 36
Early research (Phase 1)Study completedNCT00472758
What this trial is testing

Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545

Who this might be right for
Chronic Plaque Psoriasis
MedImmune LLC 40
Early research (Phase 1)Study completedNCT03062618
What this trial is testing

PRCL-02 in Healthy Volunteers and Plaque Psoriasis

Who this might be right for
Psoriasis
PRCL Research Inc. 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03997786
What this trial is testing

Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Sun Pharmaceutical Industries Limited 135
Testing effectiveness (Phase 2)Study completedNCT03553823
What this trial is testing

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

Who this might be right for
Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 40
Post-approval studies (Phase 4)UnknownNCT00707070
What this trial is testing

Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Universita di Verona 100
Early research (Phase 1)Study completedNCT03724292
What this trial is testing

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Who this might be right for
Psoriasis
Vitae Pharmaceuticals Inc., an Allergan affiliate 40
Not applicableUnknownNCT04324866
What this trial is testing

Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy

Who this might be right for
Coronavirus Infection
Universita di Verona 300
Not applicableStudy completedNCT00705900
What this trial is testing

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
NeoStrata Company, Inc. 60
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation